M&A Update – December 12

– LSXMA to combine with SIRI at a consideration estimated at 8.4x shares, 58.3% premium, $16 billion
– WH / CHH launched hostile exchange offer at $49.50 cash per share + 0.324x shares, 30.2% premium, $9.5 billion
– EGLE to be acquired by SBLK for 2.6211x shares, 17.3% premium, $916.9 million
– ICVX to be acquired by AZN for $15.00 cash per share + CVR, 47.8% premium, $838 million
– HOLI to be acquired by Ascendent Capital Partners for $26.50 cash per share, 42.0% premium, $1.66 billion
– TARO agreed in principle to acquisition by Sun Pharma at $43.00 cash per share, 46.3% premium
– MIRO / UTHR tender successful
– OPS.to / HAE deal closed
– SGEN / PFE received all regulatory approvals, closing Dec 14
– BVH / HGV filed DEFM14a, vote Jan 11, closing H1 2024
– CD / Bain Capital delisting notice, closing Dec 18
– AAIC vote
– RPT vote
– CTG tender expires